• SENSEX
    NIFTY 50
Healthcare

Indian pharma growth decelerated in March but expect good future growth, says CLSA

Updated : April 16, 2019 10:37 AM IST

Glenmark and Lupin have been delivering fast growth with March 19 sales rising 10.2 percent, according to the report,
Cipla’s growth was aided by seasonal factors while Torrent moved ahead of the market at 8 percent in March, CLSA said.
Indian pharma growth decelerated in March but expect good future growth, says CLSA

You May Also Like

Live TV
Advertisement